These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6275029)

  • 1. Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity.
    Chong KT; Mims CA
    J Gen Virol; 1981 Dec; 57(Pt 2):415-9. PubMed ID: 6275029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the morphogenesis of murine cytomegalovirus.
    Weiland F; Keil GM; Reddehase MJ; Koszinowski UH
    Intervirology; 1986; 26(4):192-201. PubMed ID: 3038772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat cytomegalovirus: studies on the viral genome and the proteins of virions and nucleocapsids.
    Meijer H; Dormans PH; Geelen JL; van Boven CP
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():681-95. PubMed ID: 6323618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of beta-2-microglobulin on the infectivity of murine cytomegalovirus.
    Wykes MN; Price P; Shellam GR
    Arch Virol; 1992; 123(1-2):59-72. PubMed ID: 1312826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empty capsids in column-purified recombinant adenovirus preparations.
    Vellekamp G; Porter FW; Sutjipto S; Cutler C; Bondoc L; Liu YH; Wylie D; Cannon-Carlson S; Tang JT; Frei A; Voloch M; Zhuang S
    Hum Gene Ther; 2001 Oct; 12(15):1923-36. PubMed ID: 11589834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the multicapsid virions of murine cytomegalovirus.
    Hudson JB; Misra V; Mosmann TR
    Virology; 1976 Jul; 72(1):224-34. PubMed ID: 180668
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection.
    Inada T; Chong KT; Mims CA
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():871-8. PubMed ID: 2984321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles.
    Irmiere A; Gibson W
    J Virol; 1985 Oct; 56(1):277-83. PubMed ID: 2993655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and separation of enveloped and unenveloped herpes simplex virus particles.
    Matis J; Lesso J; Mucha V; Matisová E
    Acta Virol; 1975 Jul; 19(4):273-80. PubMed ID: 241223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.
    Irmiere A; Gibson W
    Virology; 1983 Oct; 130(1):118-33. PubMed ID: 6314643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of mouse ectoplacental cone cells with murine cytomegalovirus.
    Baskar JF; Huang ES
    J Gen Virol; 1981 Jun; 54(Pt 2):415-20. PubMed ID: 6270259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus: purification of enveloped virions and dense bodies.
    Talbot P; Almeida JD
    J Gen Virol; 1977 Aug; 36(2):345-9. PubMed ID: 197204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in virus protein synthesis and capsid production in infection with DI particles of herpesvirus.
    Henry BE; Newcomb WW; O'Callaghan DJ
    J Gen Virol; 1980 Apr; 47(2):343-53. PubMed ID: 6245174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity of murine cytomegalovirus-infected target cells allows for release of residual infectious virus.
    Dix RD; Cousins SW
    Arch Virol; 2005 Apr; 150(4):797-803. PubMed ID: 15614430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity and immunogenicity of temperature-sensitive mutants of murine cytomegalovirus.
    Tonari Y; Minamishima Y
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1983-90. PubMed ID: 6310038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a cytomegalovirus-like agent from wild rats.
    Bruggeman CA; Meijer H; Dormans PH; Debie WM; Grauls GE; van Boven CP
    Arch Virol; 1982; 73(3-4):231-41. PubMed ID: 6293414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of virulence of murine cytomegalovirus with macrophage susceptibility and with virion-bound non-neutralizing antibody.
    Inada T; Mims CA
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():879-82. PubMed ID: 2984322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement.
    Hodgkin PD; Scalzo AA; Swaminathan N; Price P; Shellam GR
    J Virol Methods; 1988 Dec; 22(2-3):215-30. PubMed ID: 2851601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural development of guinea pig cytomegalovirus in cultured guinea pig embryo cells.
    Fong CK; Bia F; Hsiung GD; Madore P; Chang PW
    J Gen Virol; 1979 Jan; 42(1):127-40. PubMed ID: 215704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.